were the first to described cytolysis of human melanoma cells by NY-ESO-specific CD4+ T cells, that they found induced or enhanced in peripheral blood of patients treated with the anti-CTLA-4 blocking antibody ipilimumab. The gene discussed is CD4; the disease is melanoma.